These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33687579)

  • 21. Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Namdaroglu S; Kaya AH; Batgi H; Kayikci O; Dal MS; Iskender D; Kizil Cakar M; Tekgunduz E; Altuntas F
    Sci Rep; 2019 Feb; 9(1):2046. PubMed ID: 30765830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotavirus infection following post-transplantation cyclophosphamide based haploidentical hematopoietic cell transplantation in children is associated with hemophagocytic syndrome and high mortality.
    Jaiswal SR; Bhakuni P; Chakrabarti A; Chakrabarti S
    Transpl Infect Dis; 2019 Oct; 21(5):e13136. PubMed ID: 31251433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of different conditioning regimens on survival and engraftment for children with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoeitic stem cell transplantation: A single institution experience.
    Ali S; Wall DA; Ali M; Chiang KY; Naqvi A; Weitzman S; Gassas A; Gibson P; Brager R; Fernandez CV; Crooks B; Schechter T; Krueger J
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28477. PubMed ID: 33740322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Familial Hemophagocytic Lymphohistiocytosis Who Do Not Have Matched Family Donors: Experience in Oman.
    Nazir HF; Ba Alawi FS; Al Hosni S; Al Rawas A; Dennison D
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1119-1123. PubMed ID: 32088369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fanconi anemia and haploidentical stem cell transplantation.
    Medina-Valencia D; Aristizabal AM; Beltran E; Franco AA
    Pediatr Transplant; 2022 Nov; 26(7):e14348. PubMed ID: 35781747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic stem cell transplant in primary hemophagocytic lymphohistiocytosis - a single-center experience.
    Hussain F; Hussain M; Kerio AA; Ghafoor T; Khattak TA; Chaudhry QUN; Shahbaz N; Ali Khan M; Iftikhar R
    Ann Hematol; 2024 Sep; 103(9):3775-3782. PubMed ID: 39046509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.
    Ciurea SO; Zhang MJ; Bacigalupo AA; Bashey A; Appelbaum FR; Aljitawi OS; Armand P; Antin JH; Chen J; Devine SM; Fowler DH; Luznik L; Nakamura R; O'Donnell PV; Perales MA; Pingali SR; Porter DL; Riches MR; Ringdén OT; Rocha V; Vij R; Weisdorf DJ; Champlin RE; Horowitz MM; Fuchs EJ; Eapen M
    Blood; 2015 Aug; 126(8):1033-40. PubMed ID: 26130705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases.
    Even-Or E; NaserEddin A; Dinur Schejter Y; Shadur B; Zaidman I; Stepensky P
    Bone Marrow Transplant; 2021 Feb; 56(2):434-441. PubMed ID: 32855443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Allogeneic hematopoietic stem cell transplantation for hemophagocytic syndrome].
    Sun R; Xiao J; Zhang J; Lu Y; Wei Z; Zhu H; Sun Y
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):94-8. PubMed ID: 24739718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haploidentical stem cell transplantation in a boy with chronic granulomatous disease.
    Regueiro-García A; Fariña-Nogueira S; Porto-Arceo JÁ; Couselo-Sánchez JM
    Allergol Immunopathol (Madr); 2018; 46(4):385-388. PubMed ID: 29373243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.
    Cooper N; Rao K; Gilmour K; Hadad L; Adams S; Cale C; Davies G; Webb D; Veys P; Amrolia P
    Blood; 2006 Feb; 107(3):1233-6. PubMed ID: 16219800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
    Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z
    Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children.
    Bahr TL; Lund T; Sando NM; Orchard PJ; Miller WP
    Bone Marrow Transplant; 2016 Nov; 51(11):1546-1548. PubMed ID: 27376448
    [No Abstract]   [Full Text] [Related]  

  • 34. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.
    Ruggeri A; Labopin M; Bacigalupo A; Afanasyev B; Cornelissen JJ; Elmaagacli A; Itälä-Remes M; Blaise D; Meijer E; Koc Y; Milpied N; Schouten HC; Kroeger N; Mohty M; Nagler A
    J Hematol Oncol; 2018 Mar; 11(1):40. PubMed ID: 29544522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.
    Marsh RA; Vaughn G; Kim MO; Li D; Jodele S; Joshi S; Mehta PA; Davies SM; Jordan MB; Bleesing JJ; Filipovich AH
    Blood; 2010 Dec; 116(26):5824-31. PubMed ID: 20855862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
    Makanga DR; Guillaume T; Willem C; Legrand N; Gagne K; Cesbron A; Gendzekhadze K; Peterlin P; Garnier A; Le Bourgeois A; Béné MC; Chevallier P; Retière C
    J Immunol; 2020 Sep; 205(5):1441-1448. PubMed ID: 32747504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
    McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
    Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
    Sharma A; Rastogi N; Chatterjee G; Kapoor R; Nivargi S; Yadav SP
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1033-e1036. PubMed ID: 33306606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes.
    Klein OR; Bapty S; Lederman HM; Younger MEM; Zambidis ET; Jones RJ; Cooke KR; Symons HJ
    J Clin Immunol; 2021 Feb; 41(2):414-426. PubMed ID: 33159275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.